Friday - February 20, 2026

Category Archives: Pharmaceuticals & Biotech

Bispecific Antibody Competitive Landscape, Analytical Perspective, Therapeutics Assessment, Preclinical and Discovery Stage Products Report 2025

DelveInsight’s, “Bispecific antibody Competitive landscape, 2025,” report provides comprehensive insights about 180+ companies and 250+ drugs in Bispecific antibody Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the … Continue reading →

Neuromyelitis Optica Spectrum Disorder Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Neuromyelitis Optica Spectrum Disorder Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Neuromyelitis Optica Spectrum Disorder pipeline landscape. It covers the Neuromyelitis Optica Spectrum Disorder Pipeline drug profiles, including clinical and nonclinical … Continue reading →

Neuroendocrine Tumors Treatment Pipeline Shows Strong Momentum as 70+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Neuroendocrine tumors Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Neuroendocrine tumors pipeline landscape. It covers the Neuroendocrine Tumors pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Myasthenia Gravis Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Myasthenia Gravis Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Myasthenia Gravis pipeline landscape. It covers the Myasthenia Gravis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

US Pharmaceutical Drug Delivery Market to Reach $1.24 Billion by 2031 as Biologics and Home-Based Care Reshape Therapeutic Delivery Models

US Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injectable, Topical (Cream, Transdermal, Suppositories), Ocular, Nasal, Transmucosal, Implantable], Application (Cancer, Diabetes), Care Setting – Forecast to 2031 The US Pharmaceutical Drug Delivery Market is poised for sustained … Continue reading →

Europe In Vitro Diagnostics Market worth $49.49 billion by 2031, Growing at CAGR of 7.9%

Europe In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) – Forecast to 2031 The Europe In Vitro Diagnostics (IVD) Market is set for … Continue reading →

Kartoon Studios (NYSE: TOON) Gains Investor Attention – MGRX, AIOS, GFAI – Watch Video Update Now

Kartoon Studios (NYSE: TOON) is drawing renewed investor interest as momentum builds across its streaming, production, and franchise expansion strategy heading into 2026. The company, a global producer and distributor of family entertainment content, operates Kartoon Channel!—consistently ranked among the … Continue reading →

Rett Syndrome Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Rett Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Rett Syndrome pipeline landscape. It covers the Rett Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Chronic Rhinosinusitis with Nasal Polyps Clinical Trial Pipeline Expands as 8+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Chronic Rhinosinusitis with Nasal Polyps Pipeline Insight 2026” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in the Chronic Rhinosinusitis with Nasal Polyps pipeline landscape. It covers the Chronic Rhinosinusitis with Nasal Polyps Pipeline drug profiles, … Continue reading →

Stargardt Disease Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Stargardt Disease Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Stargardt Disease pipeline landscape. It covers the Stargardt Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →